Newsroom

PharmD Live® Completes $1M Seed Round Investment

PharmD Live® Completes $1M Seed Round Investment

May 16, 2022

WASHINGTON – PharmD Live® – the pharmacist-led telehealth company focused on reducing adverse drug effects – today announced the successful completion of their initial $1,000,000 seed round of investment. “PharmD Live empowers physicians to deliver...

Press Releases

PharmD Live® Completes $1M Seed Round Investment
May 16, 2022

PharmD Live® Completes $1M Seed Round Investment

WASHINGTON – PharmD Live® – the pharmacist-led telehealth company focused on reducing adverse drug effects – today...

PharmD Live Engages with Doctors, Patients, and Partners for National Diabetes Month
November 1, 2021

PharmD Live Engages with Doctors, Patients, and Partners for National Diabetes Month

WASHINGTON, DC – PharmD Live® – the pharmacist-led telehealth company focused on reducing adverse drug effects...

PharmD Live® ends October’s American Pharmacists Month
October 29, 2021

PharmD Live® ends October’s American Pharmacists Month

WASHINGTON, DC – PharmD Live® – the pharmacist-led telehealth company focused on reducing adverse drug effects...

In The News

PharmD Live Ranked Top 5 Post Acute Care Solution impacting healthcare

Global Startup Heat Map highlights 5 Top Post-Acute Care Solutions out...

PharmD Live reaches first goal on wefunder

Each year, over 100,000 adults die from Adverse Drug Reactions, the...

Media Contacts

All media inquiries can be sent to Director of Communications and Public Affairs Robert Bozzuto, [email protected], 717-418-8485

2021 FDA-Approved Medications and Treatment Guidelines Update Webinar

Join our medication experts to learn about:
1. The newly approved medications for chronic diseases in 2021
2. Noteworthy changes in the disease treatment guidelines
3. And their impact on your patient population and quality measures

Wednesday November 17 @ 1pm EST
Last Chance to register!